Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Slotman

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Endocrine Reviews|February 1, 1991
Endocrine factors in common epithelial ovarian cancerB R Rao, B J Slotman
Cancer|August 15, 1990
Survival of patients with ovarian cancer. Apart from stage and grade, tumor progesterone receptor content is a prognostic indicatorB J Slotman, J J Nauta, B R Rao
Anticancer Research|January 1, 1989
A direct LHRH-agonist action on cancer cells is unlikely to be the cause of response to LHRH-agonist treatmentB J Slotman, L G Poels, B R Rao
Nederlands Tijdschrift Voor Geneeskunde|October 16, 1993
[Palliative radiotherapy in non-small cell bronchial carcinoma]B J Slotman, K H Njo, A B Karim
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 15, 2016
The Current Role of Radiotherapy in the Treatment of Small Cell Lung CancerD K Woolf, B J Slotman, C Faivre-Finn
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 25, 1991
Correlation between nuclear DNA content and steroid receptor status in ovarian cancerB J Slotman, J P Baak, B R Rao
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 1990
Ovarian cancer: radiation sensitivity in vitroB J Slotman, A B Karim, B R Rao
Mutation Research|July 27, 2001
The importance of using absolute mutant frequencies to compare mutation spectraG K Kuipers, B J Slotman, M V Lafleur
International Journal of Radiation Oncology, Biology, Physics|April 30, 1994
Curative radiotherapy for technically operable stage I nonsmall cell lung cancerB J Slotman, K H Njo, A B Karim
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 1, 1996
Limited field irradiation in early stage (T1-2N0) non-small cell lung cancerB J Slotman, I E Antonisse, K H Njo
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Endocrine Reviews|February 1, 1991
Endocrine factors in common epithelial ovarian cancerB R Rao, B J Slotman
Cancer|August 15, 1990
Survival of patients with ovarian cancer. Apart from stage and grade, tumor progesterone receptor content is a prognostic indicatorB J Slotman, J J Nauta, B R Rao
Anticancer Research|January 1, 1989
A direct LHRH-agonist action on cancer cells is unlikely to be the cause of response to LHRH-agonist treatmentB J Slotman, L G Poels, B R Rao
Nederlands Tijdschrift Voor Geneeskunde|October 16, 1993
[Palliative radiotherapy in non-small cell bronchial carcinoma]B J Slotman, K H Njo, A B Karim
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 15, 2016
The Current Role of Radiotherapy in the Treatment of Small Cell Lung CancerD K Woolf, B J Slotman, C Faivre-Finn
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 25, 1991
Correlation between nuclear DNA content and steroid receptor status in ovarian cancerB J Slotman, J P Baak, B R Rao
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 1990
Ovarian cancer: radiation sensitivity in vitroB J Slotman, A B Karim, B R Rao
Mutation Research|July 27, 2001
The importance of using absolute mutant frequencies to compare mutation spectraG K Kuipers, B J Slotman, M V Lafleur
International Journal of Radiation Oncology, Biology, Physics|April 30, 1994
Curative radiotherapy for technically operable stage I nonsmall cell lung cancerB J Slotman, K H Njo, A B Karim
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 1, 1996
Limited field irradiation in early stage (T1-2N0) non-small cell lung cancerB J Slotman, I E Antonisse, K H Njo
Pageof 9